6SQB Sequans Communications S.A. ADS

DEADLINE ALERT: Brower Piven Reminds Investors of Upcoming Deadline in Class Action Lawsuit and Encourages Shareholders Who Have Losses in Excess of $100,000 from Investment in Sequans Communications S.A. to Contact the Firm

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Eastern District of New York on behalf of purchasers of Sequans Communications S.A. (NYSE: SQNS) (“Sequans” or the “Company”) securities during the period between April 29, 2016 through July 31, 2017, inclusive (the “Class Period”). Investors who wish to become proactively involved in the litigation have until October 10, 2017 to seek appointment as lead plaintiff.

If you wish to choose counsel to represent you and the class, you must apply to be appointed lead plaintiff and be selected by the Court. The lead plaintiff will direct the litigation and participate in important decisions including whether to accept a settlement for the class in the action. The lead plaintiff will be selected from among applicants claiming the largest loss from investment in Sequans securities during the Class Period. Members of the class will be represented by the lead plaintiff and counsel chosen by the lead plaintiff. No class has yet been certified in the above action.

The complaint accuses the defendants of violations of the Securities Exchange Act of 1934 by virtue of the defendants’ failure to disclose during the Class Period that Sequans was improperly recognizing revenue.

According to the complaint, following an August 1, 2017 announcement that second quarter revenue was negatively affected after the Company had to take product back into their inventory from an early 2016 sale related to the tablet business, the value of Sequans shares declined significantly.

If you have suffered a loss in excess of $100,000 from investment in Sequans securities purchased on or after April 29, 2016 and held through the revelation of negative information during and/or at the end of the Class Period and would like to learn more about this lawsuit and your ability to participate as a lead plaintiff, without cost or obligation to you, please visit our website at http://www.browerpiven.com/currentsecuritiescases.html. You may also request more information by contacting Brower Piven either by email at [email protected] or by telephone at (410) 415-6616.

Attorneys at Brower Piven have extensive experience in litigating securities and other class action cases and have been advocating for the rights of shareholders since the 1980s. If you choose to retain counsel, you may retain Brower Piven without financial obligation or cost to you, or you may retain other counsel of your choice. You need take no action at this time to be a member of the class.

EN
06/09/2017

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Sequans Communications S.A. ADS

Sequans Communications SA: 2 directors

Three Directors at Sequans Communications SA bought 435,000 shares at between 0.950USD and 1.088USD. The significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's direct...

 PRESS RELEASE

Sequans and AmericanPharma Technologies Team Up to Protect Covid-19 Va...

PARIS & BOISE, Idaho--(BUSINESS WIRE)-- Sequans Communications S.A. (NYSE: SQNS) has joined forces with AmericanPharma Technologies and is providing the cellular IoT connectivity solution for AmericanPharma Tech’s PharmaWatch™ vaccine monitoring system that is currently protecting Covid-19 vaccine shipments and storage around the country. PharmaWatch is connected by Sequans’ Monarch technology, enabling it to upload its vaccine temperature monitoring data to the portal every 5 minutes via a secure and reliable cellular LTE-M network transmission. “PharmaWatch provides one of the most importan...

 PRESS RELEASE

Sequans to Participate in Needham 2021 Virtual Technology and Media Co...

PARIS--(BUSINESS WIRE)-- Sequans Communications S.A. (NYSE: SQNS), leading developer and provider of 5G and 4G solutions for broadband, critical, and massive IoT, announced today Georges Karam, CEO and Deborah Choate, CFO, will participate in the Needham Technology and Media Conference being held virtually May 17-20, 2021. Sequans will conduct one-on-one meetings on Monday, May 17th and Tuesday, May 18th between 8:00 am and 1:30 pm ET. The Company will participate in a fireside chat from 8:00 am to 8:40 am ET on Monday, May 17th. For more information about the Needham conference, or to sched...

 PRESS RELEASE

Sequans Communications Announces First Quarter 2021 Financial Results

PARIS--(BUSINESS WIRE)-- Sequans Communications S.A. (NYSE: SQNS), a leading developer and provider of 5G/4G chips and modules, today announced financial results for the first quarter ended March 31, 2021. First Quarter 2021 Summary Results Table: (in US$ millions, except share and per share data) Q1 2021   Q4 2020   Q1 2020 Revenue $12.3     $15.8     $8.8   Gross profit 6.2     7.1     4.5   Gross margin (%) 50.1 %   45.1 %   51.3 % Operating loss (5.8 )   (5.4 )   (7.8 ) Net loss ...

 PRESS RELEASE

Sequans Announces $50 Million Financing to Strengthen Balance Sheet

PARIS--(BUSINESS WIRE)-- Sequans Communications S.A. (NYSE: SQNS), leading developer and provider of 5G and 4G solutions for broadband, critical, and massive IoT, announced today the signing of a $50 million private financing with Lynrock Lake Master Fund LP, a fund managed by Lynrock Lake LP (“Lynrock Lake”), an investment management firm with approximately $1.2 billion of assets under management. The financing consists of $10 million of American Depository Shares (ADS) and $40 million principal amount of convertible debt. The financing is scheduled to close April 9, 2021. “A stronger balanc...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch